Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
29
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Joshi Vaidehi | Director | 4 | $0 | $0 | 2024-08-07 |
| Gobel David | Director | 6 | $0 | $31.8K | 2024-08-07 |
| Milhous Alison Tjosvold | Director | 5 | $0 | $0 | 2024-08-07 |
| Cohen Douglas Jay | Director | 8 | $72.3K | $0 | 2024-08-07 |
| Murphy Keith | Other | 55 | $552.4K | $5.01M | 2024-08-07 |
| STERN ADAM K | Director | 7 | $0 | $0 | 2024-08-07 |
| Miner Jeffrey N. | Chief Scientific Officer | 7 | $0 | $0 | 2022-08-31 |
| JURGENSEN THOMAS E | General Counsel & Secretary | 4 | $0 | $0 | 2022-08-31 |
| Heberlig Chris | President and CFO | 1 | $0 | $0 | 2020-09-15 |
| Bush Jennifer | General Counsel & Secretary | 26 | $0 | $0 | 2020-08-18 |
| CROUCH TAYLOR | CEO & President | 15 | $0 | $0 | 2020-08-18 |
| KUSSMAN CRAIG | Chief Financial Officer | 19 | $0 | $0 | 2020-08-18 |
| Shapiro David | Director | 3 | $0 | $0 | 2019-09-05 |
| Maroun Richard E | Director | 7 | $0 | $0 | 2019-09-05 |
| BEAVER CAROLYN | Director | 3 | $0 | $0 | 2019-09-05 |
| Malloy Kirk | Director | 7 | $0 | $0 | 2019-09-05 |
| KESSEL MARK | Director | 7 | $0 | $0 | 2019-09-05 |
| Hughes Steven George | Chief Medical Officer | 3 | $0 | $6.4K | 2019-08-16 |
| Gallant Paul | General Manager | 20 | $0 | $0 | 2019-08-16 |
| Presnell Sharon Collins | EVP, Research & Development | 28 | $0 | $1.20M | 2018-11-16 |
| Baltera Robert Jr. | Director | 16 | $0 | $24.2K | 2018-07-26 |
| GLOVER JAMES T | Director | 10 | $28.0K | $0 | 2018-07-26 |
| HOWSON TAMAR D | Director | 8 | $0 | $0 | 2018-07-26 |
| David Eric | Chief Strategy Officer | 22 | $0 | $1.02M | 2017-11-16 |
| MICHAELS BARRY D | Chief Financial Officer | 33 | $40.0K | $886.7K | 2015-08-24 |
| Heyman Richard A. | Director | 4 | $0 | $0 | 2015-08-20 |
| Renard Michael | EVP of Commercial Operations | 15 | $0 | $493.6K | 2015-06-04 |
| Forgacs Andras | Director | 2 | $0 | $0 | 2012-10-18 |
| KIMBERLIN KEVIN | 10% Owner | 2 | $0 | $0 | 2012-09-27 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Murphy Keith | EXECUTIVE CHAIRMAN | A Award | 2024-08-07 | 2024-08-07 | 19,607 | — | $0 | 132,641 | SEC↗ |
| STERN ADAM K | Director | A Award | 2024-08-07 | 2024-08-09 | 19,607 | — | $0 | 58,821 | SEC↗ |
| Joshi Vaidehi | Director | A Award | 2024-08-07 | 2024-08-09 | 19,607 | — | $0 | 58,821 | SEC↗ |
| Milhous Alison Tjosvold | Director | A Award | 2024-08-07 | 2024-08-09 | 19,607 | — | $0 | 58,821 | SEC↗ |
| Cohen Douglas Jay | Director | A Award | 2024-08-07 | 2024-08-09 | 19,607 | — | $0 | 68,821 | SEC↗ |
| Gobel David | Director | A Award | 2024-08-07 | 2024-08-09 | 19,607 | — | $0 | 39,214 | SEC↗ |
| Murphy Keith | EXECUTIVE CHAIRMAN | A Award deriv | 2024-08-05 | 2024-08-07 | 574,923 | — | $0 | 574,923 | SEC↗ |
| Murphy Keith | EXECUTIVE CHAIRMAN | A Award deriv | 2024-08-05 | 2024-08-07 | 143,731 | — | $0 | 143,731 | SEC↗ |
| Joshi Vaidehi | Director | A Award | 2023-11-17 | 2023-11-17 | 19,607 | — | $0 | 39,214 | SEC↗ |
| Gobel David | Director | A Award | 2023-11-17 | 2023-11-17 | 19,607 | — | $0 | 19,607 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award | 2023-11-17 | 2023-11-17 | 19,607 | — | $0 | 113,034 | SEC↗ |
| Cohen Douglas Jay | Director | A Award | 2023-11-17 | 2023-11-17 | 19,607 | — | $0 | 49,214 | SEC↗ |
| Milhous Alison Tjosvold | Director | A Award | 2023-11-17 | 2023-11-17 | 19,607 | — | $0 | 39,214 | SEC↗ |
| STERN ADAM K | Director | A Award | 2023-11-17 | 2023-11-17 | 19,607 | — | $0 | 39,214 | SEC↗ |
| Gobel David | Director | S Sale | 2023-11-15 | 2023-11-17 | 19,607 | $1.62 | $31.8K | 0 | SEC↗ |
| Joshi Vaidehi | Director | A Award | 2022-11-10 | 2022-11-14 | 19,607 | — | $0 | 19,607 | SEC↗ |
| Cohen Douglas Jay | Director | A Award | 2022-11-10 | 2022-11-14 | 19,607 | — | $0 | 29,607 | SEC↗ |
| Milhous Alison Tjosvold | Director | A Award | 2022-11-10 | 2022-11-14 | 19,607 | — | $0 | 19,607 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award | 2022-11-10 | 2022-11-14 | 19,607 | — | $0 | 93,427 | SEC↗ |
| STERN ADAM K | Director | A Award | 2022-11-10 | 2022-11-14 | 19,607 | — | $0 | 19,607 | SEC↗ |
| Gobel David | Director | A Award | 2022-11-10 | 2022-11-14 | 19,607 | — | $0 | 19,607 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award deriv | 2022-08-31 | 2022-10-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Miner Jeffrey N. | Chief Scientific Officer | A Award deriv | 2022-08-31 | 2022-10-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| JURGENSEN THOMAS E | General Counsel & Secretary | A Award deriv | 2022-08-31 | 2022-10-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Joshi Vaidehi | Director | A Award deriv | 2022-03-08 | 2022-03-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| STERN ADAM K | Director | A Award deriv | 2021-10-07 | 2021-10-12 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Cohen Douglas Jay | Director | A Award deriv | 2021-10-07 | 2021-10-12 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award deriv | 2021-10-07 | 2021-10-12 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award deriv | 2021-10-07 | 2021-10-12 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award deriv | 2021-10-07 | 2021-10-12 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Milhous Alison Tjosvold | Director | A Award deriv | 2021-10-07 | 2021-10-12 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Miner Jeffrey N. | Chief Scientific Officer | A Award deriv | 2021-10-07 | 2021-10-12 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Miner Jeffrey N. | Chief Scientific Officer | A Award deriv | 2021-10-07 | 2021-10-12 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Miner Jeffrey N. | Chief Scientific Officer | A Award deriv | 2021-10-07 | 2021-10-12 | 52,023 | — | $0 | 52,023 | SEC↗ |
| JURGENSEN THOMAS E | General Counsel & Secretary | A Award deriv | 2021-10-07 | 2021-10-12 | 52,023 | — | $0 | 52,023 | SEC↗ |
| Gobel David | Director | A Award deriv | 2021-10-07 | 2021-10-12 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Cohen Douglas Jay | Director | P Buy | 2021-08-17 | 2021-08-19 | 1,000 | $6.72 | $6.7K | 1,000 | SEC↗ |
| Cohen Douglas Jay | Director | P Buy | 2021-08-17 | 2021-08-19 | 1,000 | $6.74 | $6.7K | 1,000 | SEC↗ |
| Cohen Douglas Jay | Director | P Buy | 2021-08-17 | 2021-08-19 | 8,750 | $6.72 | $58.8K | 10,000 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award deriv | 2021-03-08 | 2021-03-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award deriv | 2021-03-08 | 2021-03-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award deriv | 2021-03-08 | 2021-03-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| JURGENSEN THOMAS E | General Counsel & Secretary | A Award deriv | 2021-03-08 | 2021-03-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Miner Jeffrey N. | Chief Scientific Officer | A Award deriv | 2021-03-08 | 2021-03-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Miner Jeffrey N. | Chief Scientific Officer | A Award deriv | 2021-03-08 | 2021-03-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award | 2021-03-08 | 2021-03-10 | 20,000 | — | $0 | 66,320 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award deriv | 2020-09-15 | 2020-12-11 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Cohen Douglas Jay | Director | A Award deriv | 2020-09-15 | 2020-09-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Gobel David | Director | A Award deriv | 2020-09-15 | 2020-09-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Heberlig Chris | President and CFO | A Award deriv | 2020-09-15 | 2020-09-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| JURGENSEN THOMAS E | General Counsel & Secretary | A Award deriv | 2020-09-15 | 2020-09-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Milhous Alison Tjosvold | Director | A Award deriv | 2020-09-15 | 2020-09-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Miner Jeffrey N. | Chief Scientific Officer | A Award deriv | 2020-09-15 | 2020-09-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award deriv | 2020-09-15 | 2020-09-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Murphy Keith | Executive Chairman | A Award deriv | 2020-09-15 | 2020-09-17 | 130,000 | — | $0 | 130,000 | SEC↗ |
| STERN ADAM K | Director | A Award deriv | 2020-09-15 | 2020-09-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2020-08-18 | 2020-08-18 | 10,900 | $0.57 | $6.2K | 192,758 | SEC↗ |
| CROUCH TAYLOR | CEO & President | F Tax w/h | 2020-08-18 | 2020-08-18 | 5,510 | $0.57 | $3.1K | 125,144 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2020-08-18 | 2020-08-18 | 15,700 | $0.57 | $8.9K | 221,743 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2020-05-18 | 2020-05-20 | 14,630 | $0.51 | $7.5K | 203,658 | SEC↗ |
| CROUCH TAYLOR | CEO & President | F Tax w/h | 2020-05-18 | 2020-05-20 | 6,340 | $0.51 | $3.2K | 130,654 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2020-05-18 | 2020-05-20 | 18,030 | $0.51 | $9.2K | 237,443 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2020-02-19 | 2020-02-20 | 13,850 | $0.32 | $4.4K | 218,288 | SEC↗ |
| CROUCH TAYLOR | CEO & President | F Tax w/h | 2020-02-19 | 2020-02-20 | 6,045 | $0.32 | $1.9K | 136,994 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2020-02-19 | 2020-02-20 | 17,100 | $0.32 | $5.5K | 255,473 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2019-11-18 | 2019-11-19 | 11,695 | $0.45 | $5.3K | 232,138 | SEC↗ |
| CROUCH TAYLOR | CEO & President | F Tax w/h | 2019-11-18 | 2019-11-19 | 5,075 | $0.45 | $2.3K | 143,039 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2019-11-18 | 2019-11-19 | 14,410 | $0.45 | $6.5K | 272,573 | SEC↗ |
| BEAVER CAROLYN | Director | A Award deriv | 2019-09-05 | 2019-09-09 | 52,000 | — | $0 | 52,000 | SEC↗ |
| KESSEL MARK | Director | A Award deriv | 2019-09-05 | 2019-09-09 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Malloy Kirk | Director | A Award deriv | 2019-09-05 | 2019-09-09 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Maroun Richard E | Director | A Award deriv | 2019-09-05 | 2019-09-09 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Shapiro David | Director | A Award deriv | 2019-09-05 | 2019-09-09 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2019-08-16 | 2019-08-19 | 11,960 | $0.29 | $3.5K | 243,833 | SEC↗ |
| CROUCH TAYLOR | CEO & President | F Tax w/h | 2019-08-16 | 2019-08-19 | 5,300 | $0.29 | $1.5K | 148,114 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2019-08-16 | 2019-08-19 | 9,500 | $0.29 | $2.8K | 191,335 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | S Sale | 2019-08-16 | 2019-08-19 | 22,230 | $0.29 | $6.4K | 138,484 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2019-08-16 | 2019-08-19 | 14,750 | $0.29 | $4.3K | 286,983 | SEC↗ |
| BEAVER CAROLYN | Director | A Award deriv | 2019-07-08 | 2019-07-10 | 30,500 | — | $0 | 30,500 | SEC↗ |
| BEAVER CAROLYN | Director | A Award deriv | 2019-07-08 | 2019-07-10 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2019-05-16 | 2019-05-20 | 12,275 | $0.97 | $11.9K | 255,793 | SEC↗ |
| CROUCH TAYLOR | CEO & President | F Tax w/h | 2019-05-16 | 2019-05-20 | 5,465 | $0.97 | $5.3K | 153,414 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2019-05-16 | 2019-05-20 | 9,274 | $0.97 | $9.0K | 200,835 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2019-05-16 | 2019-05-20 | 15,155 | $0.97 | $14.7K | 301,733 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2019-02-19 | 2019-02-21 | 13,520 | $1.07 | $14.5K | 268,068 | SEC↗ |
| CROUCH TAYLOR | CEO & President | F Tax w/h | 2019-02-19 | 2019-02-21 | 5,665 | $1.07 | $6.1K | 158,879 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2019-02-19 | 2019-02-21 | 10,410 | $1.07 | $11.1K | 210,109 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2019-02-19 | 2019-02-21 | 16,215 | $1.07 | $17.4K | 316,888 | SEC↗ |
| Shapiro David | Director | A Award deriv | 2018-12-04 | 2018-12-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Shapiro David | Director | A Award deriv | 2018-12-04 | 2018-12-06 | 46,500 | — | $0 | 46,500 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2018-11-16 | 2018-11-20 | 11,915 | $1.07 | $12.7K | 281,588 | SEC↗ |
| CROUCH TAYLOR | CEO & President | F Tax w/h | 2018-11-16 | 2018-11-20 | 5,140 | $1.07 | $5.5K | 164,544 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2018-11-16 | 2018-11-20 | 9,450 | $1.07 | $10.1K | 220,519 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2018-11-16 | 2018-11-20 | 14,720 | $1.07 | $15.8K | 333,103 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | F Tax w/h | 2018-11-16 | 2018-11-20 | 11,200 | $1.07 | $12.0K | 280,993 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | S Sale | 2018-11-08 | 2018-11-13 | 40,000 | $1.27 | $50.8K | 292,193 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2018-08-16 | 2018-08-16 | 12,400 | $1.11 | $13.8K | 293,503 | SEC↗ |
| CROUCH TAYLOR | CEO & President | F Tax w/h | 2018-08-16 | 2018-08-16 | 5,350 | $1.11 | $5.9K | 169,684 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2018-08-16 | 2018-08-16 | 9,835 | $1.11 | $10.9K | 229,969 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2018-08-16 | 2018-08-16 | 15,320 | $1.11 | $17.0K | 347,823 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | F Tax w/h | 2018-08-16 | 2018-08-16 | 11,655 | $1.11 | $12.9K | 332,193 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | A Award deriv | 2018-08-15 | 2018-08-16 | 675,000 | — | $0 | 675,000 | SEC↗ |
| CROUCH TAYLOR | CEO & President | A Award deriv | 2018-08-15 | 2018-08-16 | 1,350,000 | — | $0 | 1,350,000 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | A Award deriv | 2018-08-15 | 2018-08-16 | 675,000 | — | $0 | 675,000 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | A Award deriv | 2018-08-15 | 2018-08-16 | 675,000 | — | $0 | 675,000 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | A Award deriv | 2018-08-14 | 2018-08-15 | 974,694 | — | $0 | 974,694 | SEC↗ |
| Hughes Steven George | Chief Medical Officer | A Award | 2018-08-14 | 2018-08-15 | 160,714 | — | $0 | 160,714 | SEC↗ |
| Baltera Robert Jr. | Director | A Award deriv | 2018-07-26 | 2018-07-30 | 45,500 | — | $0 | 45,550 | SEC↗ |
| GLOVER JAMES T | Director | A Award deriv | 2018-07-26 | 2018-07-30 | 45,500 | — | $0 | 45,550 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2018-07-26 | 2018-07-30 | 45,500 | — | $0 | 45,550 | SEC↗ |
| KESSEL MARK | Director | A Award deriv | 2018-07-26 | 2018-07-30 | 45,500 | — | $0 | 45,550 | SEC↗ |
| Malloy Kirk | Director | A Award deriv | 2018-07-26 | 2018-07-30 | 45,500 | — | $0 | 45,550 | SEC↗ |
| Maroun Richard E | Director | A Award deriv | 2018-07-26 | 2018-07-30 | 45,500 | — | $0 | 45,550 | SEC↗ |
| CROUCH TAYLOR | CEO & President | F Tax w/h | 2018-06-25 | 2018-06-26 | 15,490 | $1.43 | $22.2K | 175,034 | SEC↗ |
| CROUCH TAYLOR | CEO & President | A Award | 2018-06-22 | 2018-06-26 | 41,764 | — | $0 | 190,524 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | A Award deriv | 2018-05-24 | 2018-05-29 | 283,333 | — | $0 | 283,333 | SEC↗ |
| CROUCH TAYLOR | CEO & President | A Award deriv | 2018-05-24 | 2018-05-29 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Gallant Paul | General Manager | A Award deriv | 2018-05-24 | 2018-05-29 | 266,667 | — | $0 | 266,667 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | A Award deriv | 2018-05-24 | 2018-05-29 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | A Award deriv | 2018-05-24 | 2018-05-29 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | A Award | 2018-05-24 | 2018-05-29 | 70,248 | — | $0 | 305,903 | SEC↗ |
| CROUCH TAYLOR | CEO & President | A Award | 2018-05-24 | 2018-05-29 | 148,760 | — | $0 | 148,760 | SEC↗ |
| Gallant Paul | General Manager | A Award | 2018-05-24 | 2018-05-29 | 66,115 | — | $0 | 239,804 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | A Award | 2018-05-24 | 2018-05-29 | 74,380 | — | $0 | 363,143 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | A Award | 2018-05-24 | 2018-05-29 | 74,380 | — | $0 | 343,848 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2018-05-16 | 2018-05-17 | 9,160 | $1.66 | $15.2K | 235,655 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2018-05-16 | 2018-05-17 | 6,890 | $1.66 | $11.4K | 173,689 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2018-05-16 | 2018-05-17 | 11,720 | $1.66 | $19.5K | 288,763 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | F Tax w/h | 2018-05-16 | 2018-05-17 | 8,325 | $1.66 | $13.8K | 269,468 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2018-02-16 | 2018-02-20 | 10,365 | $1.09 | $11.3K | 244,815 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2018-02-16 | 2018-02-20 | 7,820 | $1.09 | $8.5K | 180,579 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2018-02-16 | 2018-02-20 | 13,265 | $1.09 | $14.5K | 300,483 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | F Tax w/h | 2018-02-16 | 2018-02-20 | 9,420 | $1.09 | $10.3K | 277,793 | SEC↗ |
| Murphy Keith | Other | P Buy | 2017-11-24 | 2017-12-04 | 200,500 | $1.49 | $298.7K | 6,373,673 | SEC↗ |
| Murphy Keith | Other | P Buy | 2017-11-22 | 2017-12-04 | 135,000 | $1.50 | $202.5K | 6,173,173 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2017-11-16 | 2017-11-16 | 8,900 | $1.47 | $13.1K | 255,180 | SEC↗ |
| David Eric | CSO & EVP Pre-Clinical Dev | F Tax w/h | 2017-11-16 | 2017-11-16 | 5,625 | $1.47 | $8.3K | 876,609 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2017-11-16 | 2017-11-16 | 7,015 | $1.47 | $10.3K | 188,399 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2017-11-16 | 2017-11-16 | 11,890 | $1.47 | $17.5K | 313,748 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | F Tax w/h | 2017-11-16 | 2017-11-16 | 5,860 | $1.47 | $8.6K | 287,213 | SEC↗ |
| Baltera Robert Jr. | Director | A Award deriv | 2017-08-24 | 2017-08-28 | 42,500 | — | $0 | 42,500 | SEC↗ |
| GLOVER JAMES T | Director | A Award deriv | 2017-08-24 | 2017-08-28 | 42,500 | — | $0 | 42,500 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2017-08-24 | 2017-08-28 | 42,500 | — | $0 | 42,500 | SEC↗ |
| KESSEL MARK | Director | A Award deriv | 2017-08-24 | 2017-08-28 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Malloy Kirk | Director | A Award deriv | 2017-08-24 | 2017-08-28 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Maroun Richard E | Director | A Award deriv | 2017-08-24 | 2017-08-28 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2017-08-16 | 2017-08-17 | 5,871 | $2.06 | $12.1K | 264,080 | SEC↗ |
| David Eric | CSO & EVP Pre-Clinical Dev | F Tax w/h | 2017-08-16 | 2017-08-17 | 8,469 | $2.06 | $17.4K | 882,234 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2017-08-16 | 2017-08-17 | 7,324 | $2.06 | $15.1K | 195,414 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | F Tax w/h | 2017-08-16 | 2017-08-17 | 26,362 | $2.06 | $54.3K | 325,638 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | F Tax w/h | 2017-08-16 | 2017-08-17 | 6,115 | $2.06 | $12.6K | 293,073 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | A Award | 2017-06-27 | 2017-06-29 | 190,000 | — | $0 | 269,951 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | A Award | 2017-06-27 | 2017-06-29 | 35,000 | — | $0 | 79,951 | SEC↗ |
| David Eric | CSO & EVP Pre-Clinical Dev | A Award | 2017-06-27 | 2017-06-29 | 190,000 | — | $0 | 890,703 | SEC↗ |
| Gallant Paul | General Manager | A Award | 2017-06-27 | 2017-06-29 | 160,000 | — | $0 | 202,738 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | A Award | 2017-06-27 | 2017-06-29 | 220,000 | — | $0 | 352,000 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | A Award | 2017-06-27 | 2017-06-29 | 200,000 | — | $0 | 299,188 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | F Tax w/h | 2017-05-16 | 2017-05-17 | 1,167 | $2.86 | $3.3K | 99,188 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2017-05-16 | 2017-05-17 | 1,235 | $2.86 | $3.5K | 44,951 | SEC↗ |
| David Eric | CSO & EVP Pre-Clinical Dev | F Tax w/h | 2017-05-16 | 2017-05-17 | 1,263 | $2.86 | $3.6K | 700,703 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2017-05-16 | 2017-05-17 | 1,317 | $2.86 | $3.8K | 42,738 | SEC↗ |
| CROUCH TAYLOR | CEO & President | A Award deriv | 2017-04-24 | 2017-04-24 | 2,088,212 | — | $0 | 2,088,212 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2017-02-16 | 2017-02-21 | 1,390 | $2.95 | $4.1K | 46,186 | SEC↗ |
| David Eric | CSO & EVP Pre-Clinical Dev | F Tax w/h | 2017-02-16 | 2017-02-21 | 1,390 | $2.95 | $4.1K | 701,966 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2017-02-16 | 2017-02-21 | 1,320 | $2.95 | $3.9K | 44,055 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | F Tax w/h | 2017-02-16 | 2017-02-21 | 5,742 | $2.95 | $16.9K | 6,038,173 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | F Tax w/h | 2017-02-16 | 2017-02-21 | 1,390 | $2.95 | $4.1K | 115,355 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | S Sale | 2017-02-09 | 2017-02-10 | 25,000 | $3.68 | $92.0K | 6,043,915 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | M Exercise deriv | 2017-02-08 | 2017-02-10 | 30,000 | — | $0 | 0 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | M Exercise | 2017-02-08 | 2017-02-10 | 30,000 | $1.00 | $30.0K | 6,068,915 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | S Sale | 2017-01-24 | 2017-01-25 | 20,100 | $3.50 | $70.3K | 6,038,915 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | S Sale | 2017-01-23 | 2017-01-25 | 4,900 | $3.51 | $17.2K | 6,059,015 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | S Sale | 2016-12-14 | 2016-12-15 | 50,000 | $3.72 | $186.0K | 6,063,915 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2016-11-16 | 2016-11-18 | 1,210 | $3.26 | $3.9K | 47,576 | SEC↗ |
| David Eric | CSO & EVP Pre-Clinical Dev | F Tax w/h | 2016-11-16 | 2016-11-18 | 1,745 | $3.26 | $5.7K | 703,356 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2016-11-16 | 2016-11-18 | 1,160 | $3.26 | $3.8K | 45,375 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | F Tax w/h | 2016-11-16 | 2016-11-18 | 7,200 | $3.26 | $23.5K | 6,113,915 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | F Tax w/h | 2016-11-16 | 2016-11-18 | 1,210 | $3.26 | $3.9K | 116,745 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | F Tax w/h | 2016-09-16 | 2016-09-20 | 1,394 | $4.00 | $5.6K | 6,121,115 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | A Award deriv | 2016-08-23 | 2016-08-23 | 330,000 | — | $0 | 330,000 | SEC↗ |
| KUSSMAN CRAIG | Chief Financial Officer | A Award | 2016-08-23 | 2016-08-23 | 132,000 | — | $0 | 132,000 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | F Tax w/h | 2016-08-19 | 2016-08-23 | 1,214 | $4.00 | $4.9K | 48,786 | SEC↗ |
| David Eric | CSO & EVP Pre-Clinical Dev | F Tax w/h | 2016-08-19 | 2016-08-23 | 1,205 | $4.00 | $4.8K | 705,101 | SEC↗ |
| Gallant Paul | General Manager | F Tax w/h | 2016-08-19 | 2016-08-23 | 965 | $4.00 | $3.9K | 46,535 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | F Tax w/h | 2016-08-19 | 2016-08-23 | 5,129 | $4.00 | $20.5K | 6,122,509 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | F Tax w/h | 2016-08-19 | 2016-08-23 | 1,109 | $4.00 | $4.4K | 117,955 | SEC↗ |
| Baltera Robert Jr. | Director | A Award deriv | 2016-08-17 | 2016-08-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| GLOVER JAMES T | Director | A Award deriv | 2016-08-17 | 2016-08-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2016-08-17 | 2016-08-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| KESSEL MARK | Director | A Award deriv | 2016-08-17 | 2016-08-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| KESSEL MARK | Director | A Award deriv | 2016-08-17 | 2016-08-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Malloy Kirk | Director | A Award deriv | 2016-08-17 | 2016-08-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Maroun Richard E | Director | A Award deriv | 2016-08-17 | 2016-08-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Maroun Richard E | Director | A Award deriv | 2016-08-17 | 2016-08-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Baltera Robert Jr. | Director | A Award | 2016-08-17 | 2016-08-19 | 7,500 | — | $0 | 146,006 | SEC↗ |
| GLOVER JAMES T | Director | A Award | 2016-08-17 | 2016-08-19 | 7,500 | — | $0 | 17,500 | SEC↗ |
| HOWSON TAMAR D | Director | A Award | 2016-08-17 | 2016-08-19 | 7,500 | — | $0 | 7,500 | SEC↗ |
| KESSEL MARK | Director | A Award | 2016-08-17 | 2016-08-19 | 7,500 | — | $0 | 15,000 | SEC↗ |
| KESSEL MARK | Director | A Award | 2016-08-17 | 2016-08-19 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Malloy Kirk | Director | A Award | 2016-08-17 | 2016-08-19 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Maroun Richard E | Director | A Award | 2016-08-17 | 2016-08-19 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Maroun Richard E | Director | A Award | 2016-08-17 | 2016-08-19 | 7,500 | — | $0 | 15,000 | SEC↗ |
| David Eric | CSO & EVP Pre-Clinical Dev | S Sale | 2016-08-05 | 2016-08-09 | 20,000 | $4.55 | $91.0K | 706,306 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | A Award deriv | 2016-07-11 | 2016-07-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| David Eric | CSO & EVP Pre-Clinical Dev | A Award deriv | 2016-07-11 | 2016-07-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Gallant Paul | General Manager | A Award deriv | 2016-07-11 | 2016-07-13 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | A Award deriv | 2016-07-11 | 2016-07-13 | 415,000 | — | $0 | 415,000 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | A Award deriv | 2016-07-11 | 2016-07-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Bush Jennifer | General Counsel & Secretary | A Award | 2016-07-11 | 2016-07-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| David Eric | CSO & EVP Pre-Clinical Dev | A Award | 2016-07-11 | 2016-07-13 | 50,000 | — | $0 | 726,306 | SEC↗ |
| Gallant Paul | General Manager | A Award | 2016-07-11 | 2016-07-13 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | A Award | 2016-07-11 | 2016-07-13 | 208,000 | — | $0 | 6,127,638 | SEC↗ |
| Presnell Sharon Collins | Chief Scientific Officer | A Award | 2016-07-11 | 2016-07-13 | 50,000 | — | $0 | 119,064 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | A Award deriv | 2016-02-16 | 2016-02-18 | 24,690 | — | $0 | 24,690 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | F Tax w/h | 2016-02-16 | 2016-02-18 | 24,690 | $2.04 | $50.4K | 5,919,638 | SEC↗ |
| Baltera Robert Jr. | Director | S Sale | 2015-09-21 | 2015-09-23 | 6,000 | $4.03 | $24.2K | 138,506 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | A Award deriv | 2015-08-24 | 2015-08-24 | 100,692 | — | $0 | 100,692 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | F Tax w/h | 2015-08-24 | 2015-08-24 | 100,692 | $2.32 | $233.6K | 86,808 | SEC↗ |
| Gallant Paul | General Manager | A Award deriv | 2015-08-20 | 2015-08-24 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Baltera Robert Jr. | Director | A Award deriv | 2015-08-20 | 2015-08-24 | 37,000 | — | $0 | 37,000 | SEC↗ |
| GLOVER JAMES T | Director | A Award deriv | 2015-08-20 | 2015-08-24 | 37,000 | — | $0 | 37,000 | SEC↗ |
| Heyman Richard A. | Director | A Award deriv | 2015-08-20 | 2015-08-24 | 37,000 | — | $0 | 37,000 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2015-08-20 | 2015-08-24 | 37,000 | — | $0 | 37,000 | SEC↗ |
| Malloy Kirk | Director | A Award deriv | 2015-08-20 | 2015-08-24 | 37,000 | — | $0 | 37,000 | SEC↗ |
| GLOVER JAMES T | Director | P Buy | 2015-08-13 | 2015-08-13 | 10,000 | $2.80 | $28.0K | 10,000 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | P Buy | 2015-08-12 | 2015-08-13 | 20,000 | $2.56 | $51.2K | 5,944,328 | SEC↗ |
| Bush Jennifer | General Counsel | A Award deriv | 2015-06-04 | 2015-06-08 | 125,000 | — | $0 | 125,000 | SEC↗ |
| David Eric | CSO & EVP Pre-Clinical Dev | A Award deriv | 2015-06-04 | 2015-06-08 | 130,000 | — | $0 | 130,000 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | A Award deriv | 2015-06-04 | 2015-06-08 | 255,000 | — | $0 | 255,000 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | A Award deriv | 2015-06-04 | 2015-06-08 | 465,000 | — | $0 | 465,000 | SEC↗ |
| Presnell Sharon Collins | EVP, Research & Dev & CTO | A Award deriv | 2015-06-04 | 2015-06-08 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | A Award deriv | 2015-06-04 | 2015-06-08 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Presnell Sharon Collins | EVP, Research & Dev & CTO | M Exercise deriv | 2015-03-12 | 2015-03-16 | 50,000 | — | $0 | 622,192 | SEC↗ |
| Presnell Sharon Collins | EVP, Research & Dev & CTO | M Exercise | 2015-03-12 | 2015-03-16 | 50,000 | $0.08 | $4.0K | 74,064 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | A Award deriv | 2015-02-13 | 2015-02-18 | 28,008 | — | $0 | 28,008 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | F Tax w/h | 2015-02-13 | 2015-02-18 | 28,008 | $6.34 | $177.6K | 5,961,328 | SEC↗ |
| David Eric | Chief Strategy Officer | S Sale | 2014-12-30 | 2014-12-31 | 16,300 | $7.56 | $123.2K | 681,306 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | S Sale | 2014-12-30 | 2014-12-31 | 10,500 | $7.50 | $78.8K | 285,646 | SEC↗ |
| David Eric | Chief Strategy Officer | S Sale | 2014-12-29 | 2014-12-31 | 3,700 | $7.50 | $27.8K | 697,706 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | S Sale | 2014-12-29 | 2014-12-31 | 4,500 | $7.50 | $33.8K | 296,146 | SEC↗ |
| Malloy Kirk | Director | A Award deriv | 2014-12-05 | 2014-12-09 | 56,500 | — | $0 | 56,500 | SEC↗ |
| Bush Jennifer | General Counsel | A Award deriv | 2014-11-06 | 2014-11-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Presnell Sharon Collins | EVP, Research & Dev & CTO | S Sale | 2014-10-06 | 2014-10-08 | 50,000 | $6.11 | $305.5K | 24,064 | SEC↗ |
| David Eric | Chief Strategy Officer | S Sale | 2014-09-12 | 2014-09-16 | 30,000 | $7.30 | $219.0K | 701,306 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | G Gift | 2014-09-11 | 2014-12-31 | 300,646 | — | $0 | 187,500 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | M Exercise deriv | 2014-08-26 | 2014-08-28 | 13,157 | — | $0 | 27,343 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | M Exercise deriv | 2014-08-26 | 2014-08-28 | 5,317 | — | $0 | 94,683 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | M Exercise | 2014-08-26 | 2014-08-28 | 13,157 | $2.25 | $29.6K | 482,829 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | M Exercise | 2014-08-26 | 2014-08-28 | 5,317 | $3.93 | $20.9K | 488,146 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | A Award deriv | 2014-08-25 | 2014-08-26 | 102,760 | — | $0 | 102,760 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | F Tax w/h | 2014-08-25 | 2014-08-26 | 102,760 | $7.94 | $815.9K | 469,672 | SEC↗ |
| Baltera Robert Jr. | Director | A Award deriv | 2014-08-20 | 2014-08-26 | 31,500 | — | $0 | 31,500 | SEC↗ |
| Heyman Richard A. | Director | A Award deriv | 2014-08-20 | 2014-08-26 | 31,500 | — | $0 | 31,500 | SEC↗ |
| GLOVER JAMES T | Director | A Award deriv | 2014-08-20 | 2014-08-26 | 31,500 | — | $0 | 31,500 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2014-08-20 | 2014-08-26 | 31,500 | — | $0 | 31,500 | SEC↗ |
| Baltera Robert Jr. | Director | X Exercise deriv | 2014-06-06 | 2014-06-09 | 3,000 | — | $0 | 0 | SEC↗ |
| Baltera Robert Jr. | Director | X Exercise | 2014-06-06 | 2014-06-09 | 3,000 | $1.00 | $3.0K | 144,506 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | M Exercise deriv | 2014-05-08 | 2014-05-12 | 50,000 | — | $0 | 500,000 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | M Exercise | 2014-05-08 | 2014-05-12 | 50,000 | $1.65 | $82.5K | 50,000 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | M Exercise deriv | 2014-02-21 | 2014-02-21 | 10,000 | — | $0 | 550,000 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | M Exercise | 2014-02-21 | 2014-02-21 | 10,000 | $1.65 | $16.5K | 10,000 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | S Sale | 2014-02-21 | 2014-02-21 | 10,000 | $10.65 | $106.5K | 0 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | A Award deriv | 2014-02-19 | 2014-02-20 | 27,307 | — | $0 | 27,307 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | A Award deriv | 2014-02-19 | 2014-02-20 | 550,000 | — | $0 | 550,000 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | A Award deriv | 2014-02-19 | 2014-02-21 | 155,000 | — | $0 | 155,000 | SEC↗ |
| David Eric | Chief Strategy Officer | A Award deriv | 2014-02-19 | 2014-02-21 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Presnell Sharon Collins | EVP, Research & Dev & CTO | A Award deriv | 2014-02-19 | 2014-02-21 | 155,000 | — | $0 | 155,000 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | A Award deriv | 2014-02-19 | 2014-02-21 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | A Award | 2014-02-19 | 2014-02-20 | 50,000 | — | $0 | 6,024,643 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | F Tax w/h | 2014-02-19 | 2014-02-20 | 27,307 | $9.86 | $269.2K | 5,997,336 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | S Sale | 2014-02-18 | 2014-02-20 | 100,000 | $9.82 | $982.0K | 5,974,643 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | A Award deriv | 2014-02-13 | 2014-02-13 | 27,105 | — | $0 | 27,105 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | M Exercise deriv | 2014-02-13 | 2014-02-13 | 22,000 | — | $0 | 40,500 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | F Tax w/h | 2014-02-13 | 2014-02-13 | 27,105 | $9.92 | $268.9K | 6,074,643 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | M Exercise | 2014-02-13 | 2014-02-13 | 22,000 | $2.25 | $49.5K | 572,432 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | M Exercise deriv | 2014-01-29 | 2014-01-29 | 30,000 | — | $0 | 560,000 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | M Exercise | 2014-01-29 | 2014-01-29 | 30,000 | $1.65 | $49.5K | 30,000 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | S Sale | 2014-01-29 | 2014-01-29 | 30,000 | $9.93 | $297.9K | 0 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | M Exercise deriv | 2014-01-27 | 2014-01-29 | 10,000 | — | $0 | 590,000 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | M Exercise | 2014-01-27 | 2014-01-29 | 10,000 | $1.65 | $16.5K | 10,000 | SEC↗ |
| Renard Michael | EVP of Commercial Operations | S Sale | 2014-01-27 | 2014-01-29 | 10,000 | $8.92 | $89.2K | 0 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | S Sale | 2014-01-21 | 2014-01-23 | 100,000 | $10.86 | $1.09M | 6,101,748 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | M Exercise deriv | 2013-12-20 | 2013-12-20 | 47,619 | — | $0 | 32,068 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | M Exercise | 2013-12-20 | 2013-12-20 | 47,619 | $2.10 | $100.0K | 550,432 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | S Sale | 2013-12-16 | 2013-12-18 | 85,353 | $9.07 | $774.2K | 502,813 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | S Sale | 2013-12-10 | 2013-12-12 | 100,000 | $10.08 | $1.01M | 6,201,748 | SEC↗ |
| David Eric | Chief Strategy Officer | S Sale | 2013-11-13 | 2013-11-15 | 16,470 | $10.39 | $171.1K | 731,306 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | S Sale | 2013-11-13 | 2013-11-15 | 100,000 | $9.64 | $964.0K | 6,301,748 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | S Sale | 2013-10-18 | 2013-10-18 | 30,000 | $6.63 | $198.9K | 6,401,748 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | S Sale | 2013-10-16 | 2013-10-18 | 70,000 | $5.76 | $403.2K | 6,431,748 | SEC↗ |
| David Eric | Chief Strategy Officer | X Exercise deriv | 2013-10-10 | 2013-10-15 | 20,000 | — | $0 | 0 | SEC↗ |
| David Eric | Chief Strategy Officer | X Exercise | 2013-10-10 | 2013-10-15 | 20,000 | $1.00 | $20.0K | 751,306 | SEC↗ |
| David Eric | Chief Strategy Officer | S Sale | 2013-10-10 | 2013-10-15 | 3,530 | $5.66 | $20.0K | 747,776 | SEC↗ |
| David Eric | Chief Strategy Officer | S Sale | 2013-10-07 | 2013-10-09 | 63,000 | $5.86 | $369.2K | 731,306 | SEC↗ |
| Presnell Sharon Collins | EVP, Research & Dev & CTO | S Sale | 2013-10-02 | 2013-10-04 | 75,000 | $5.64 | $423.0K | 74,064 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | A Award deriv | 2013-08-28 | 2013-08-30 | 54,654 | — | $0 | 54,654 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | A Award | 2013-08-28 | 2013-08-30 | 100,000 | — | $0 | 6,556,402 | SEC↗ |
| Murphy Keith | Chairman, CEO and President | F Tax w/h | 2013-08-28 | 2013-08-30 | 54,654 | $5.60 | $306.1K | 6,501,748 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | A Award deriv | 2013-08-23 | 2013-08-26 | 102,147 | — | $0 | 102,147 | SEC↗ |
| MICHAELS BARRY D | Chief Financial Officer | F Tax w/h | 2013-08-23 | 2013-08-26 | 102,147 | $5.50 | $561.8K | 588,166 | SEC↗ |